...
首页> 外文期刊>Angewandte Chemie >Small-Molecule Control of Intracellular Protein Levels through Modulation of the Uhiquitin Proteasome System
【24h】

Small-Molecule Control of Intracellular Protein Levels through Modulation of the Uhiquitin Proteasome System

机译:通过调节泛素蛋白酶体系统的小分子控制细胞内蛋白质水平。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Traditionally, biological probes and drugs have targeted the activities of proteins (such as enzymes and receptors) that can be readily controlled by small molecules. The remaining majority of the proteome has been deemed "undruggable". By using small-molecule modulators of the ubiquitin proteasome, protein levels, rather than protein activity, can be targeted instead, thus increasing the number of druggable targets. Whereas targeting of the proteasome itself can lead to a global increase in protein levels, the targeting of other components of the UPS (e.g., the E3 ubiquitin ligases) can lead to an increase in protein levels in a more targeted fashion. Alternatively, multiple strategies for inducing protein degradation with small-molecule probes are emerging. With the ability to induce and inhibit the degradation of targeted proteins, small-molecule modulators of the UPS have the potential to significantly expand the druggable portion of the proteome beyond traditional targets, such as enzymes and receptors.
机译:传统上,生物探针和药物的目标是蛋白质(例如酶和受体)的活性,而蛋白质的活性很容易被小分子控制。蛋白质组的其余大部分被认为是“不可吸收的”。通过使用泛素蛋白酶体的小分子调节剂,可以靶向蛋白质水平而不是蛋白质活性,从而增加了可药物靶向的数量。蛋白酶体本身的靶向可导致蛋白质水平的总体升高,而UPS的其他成分(例如E3泛素连接酶)的靶向可导致蛋白水平的提高,从而更具靶向性。备选地,出现了利用小分子探针诱导蛋白质降解的多种策略。具有诱导和抑制目标蛋白质降解的能力,UPS的小分子调节剂具有将蛋白质组中可药用部分显着扩展到传统目标(例如酶和受体)之外的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号